STAT+: Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pill
Amid rising concern over efforts to contain HIV, Merck has reached voluntary licensing deals with seven companies to...
Amid rising concern over efforts to contain HIV, Merck has reached voluntary licensing deals with seven companies to...
A FDA autorizou a pílula Lipfendra, da Merck, para tratamento de colesterol elevado, facilitando o acesso a...